SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001193125-24-150516
Filing Date
2024-05-30
Accepted
2024-05-30 17:20:30
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-05-30

Document Format Files

Seq Description Document Type Size
1 ARS d777600dars.pdf ARS 3132149
  Complete submission text file 0001193125-24-150516.txt   4315741
Mailing Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494 617-916-5445
Candel Therapeutics, Inc. (Filer) CIK: 0001841387 (see all company filings)

IRS No.: 522214851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-40629 | Film No.: 241006688
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)